News
The Pancreatic Cancer Therapy Market is one of the rapidly expanding sectors within the global oncology industry. Pancreatic cancer is known for its aggressive nature, with a low survival rate, making ...
The pharma giant is wagering potentially billions of dollars on technology from ABL Bio that’s designed to get drugs across ...
Startup Gameto has developed a technique for maturing eggs outside the body that’s showing promise at helping patients get ...
GSK has continued to flesh out its neuroscience strategy with a 2 billion pound sterling ($2.5 billion) deal to use a South ...
Expanding Demand Across Hormonal Health: Market Outlook The Europe Hormone Replacement Therapy (HRT) market continues on a ...
The EU approved AstraZeneca's Enhertu for certain breast cancer patients and Imfinzi for resectable NSCLC, showing ...
The global point of care blood testing devices market is on a rapid upward trajectory, with projections indicating a remarkable expansion to an estimated value of USD 49,973.6 million by 2032. This ...
Short-term GHRT was effective and safe without increased risk for cancers among real-world adults with growth hormone deficiency.
Beijing-based feed group Dabeinong said on Thursday that three genetically modified soybean varieties developed by its biotech unit have been approved for planting by Uruguay's authorities.
Family-controlled Spanish pharma company Esteve has signed a license and supply agreement with Eton Pharmaceuticals (Nasdaq: ...
Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...
11d
Zacks Investment Research on MSNPromising Genomics & Synthetic Biology Stocks to Consider in 2025Genomics encompasses the study of a complete set of genes, their work process, and their way of interacting with each other and the environment. While it incorporates elements of genetics, the primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results